Welcome back to The Deal Room where I get the latest thoughts from our Director of Corporate Finance Stephen Barnett as he connects the dots from classroom theory to real-life examples in the news this week.

In this episode, we cover:

- Big Pharma dealmaking recovers with $85bn M&A splurge. What makes this sector unique and how are different deal teams structured in an investment bank?

- Sticking with the AI theme, Artificial intelligence startup Cohere has raised $270mn from a mix of venture capital and strategic investors including Oracle and Nvidia. We haven't discussed venture funding so far so we deep dive into what you need to know and the tactics behind big business strategy

- Kim Kardashian recently presented her debut private equity fund to a sea of curious investors in Berlin at the SuperReturn conference. Find out what's the story, the structure of the fund and whether Kim has a unique edge.

Free daily newsletter https://bit.ly/3Oeu4Wk

Free Finance Accelerator simulation https://bit.ly/3GoyV5r

Connect with Anthony https://www.linkedin.com/in/anthonycheung10/

Connect with Stephen https://www.linkedin.com/in/stephen-barnett-0b8b3337/

Hosted on Acast. See acast.com/privacy for more information.

The Deal Room: Big Pharma M&A Splurge & Kim Kardashian's Private Equity Fund 37:08 Share

Market Maker

Shownotes Transcript

The Deal Room: Big Pharma M&A Splurge & Kim Kardashian's Private Equity Fund